[1] Tang KS, Medeiros ED, Shah AD. Wide pulse pressure: A clinical review[J]. J Clin Hypertens (Greenwich),2020 Nov,22(11):1960-1967. [2] Lempiäinen PA, Ylitalo A, Huikuri H, et al. Nighttime ambulatory pulse pressure predicts cardiovascular and all-cause mortality among middle-aged participants in the 21-year follow-up[J]. J Clin Hypertens (Greenwich), 2021 Aug,23(8):1547-1555. [3] Lee JW, Shin SJ, Kim J, et al. Higher Pulse Pressure Is Associated With Increased Risk of Cardio-cerebrovascular Disease and All-Cause Mortality: A Korea n National Cohort Study[J]. Am J Hypertens, 2022 Jul 1,35(7):647-655. [4] Schram MT, Chaturvedi N, Fuller JH,et al. Pulse pressure is associated with age and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study[J]. J Hypertens, 2003 Nov,21(11):2035-44. [5] Takegami M, Ushigome E, Hata S, et al. Home-measured pulse pressure is a predictor of cardiovascular disease in type 2 diabetes: The KAMOGAWA-HBP study[J]. Nutr Metab Cardiovasc Dis, 2022 Oct,32(10):2330-2337. [6] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409. [7] Chen Y, Zhang XP, Yuan J, et al. Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study[J]. BMJ Open, 2018 Sep 28, 8(9): e021768. [8] 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志,2019,24(1):24-56. [9] Metcalf PA, Meyer ML, Tanaka H,et al. Longitudinal associations of blood pressure with aortic stiffness and pulsatility: the Atherosclerosis Risk in Communities Study[J]. J Hypertens,2021 May 1,39(5):987-993. [10] Chirinos JA, Segers P, Gillebert TC, et al. Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes: the Asklepios study[J]. Diabetes Care, 2013 Aug,36(8):2359-65. [11] Ohnishi H, Saitoh S, Takagi S, et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno and Sobetsu study[J]. Diabetes Care, 2003 Feb,26(2):437-40. [12] Li CH, Lu FH, Yang YC, et al. Increased Arterial Stiffness in Prediabetic Subjects Recognized by Hemoglobin A1c with Postprandial Glucose but Not Fasting Glucose Levels[J]. J Clin Med, 2019 May 1,8(5):603. [13] Dart AM. Pulse Pressure and Diabetic Eye Disease[J]. J Am Heart Assoc, 2019 Apr 16,8(8):e012491. [14] Yasuno S, Ueshima K, Oba K, et al. Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial[J]. Diabetes Care, 2010 May,33(5):1122-7. [15] Janghorbani M, Amini M.Comparison of systolic and diastolic blood pressure with pulse pressure and mean arterial pressure for prediction of type 2 diabetes: the Isfahan Diabetes Prevention Study[J]. Endokrynol Pol, 2011,62(4):324-30. [16] 李尉键, 方伟, 蔡泽锋, 等. 高血压人群脉压与新发糖尿病的关系探讨[J] . 中华心血管病杂志, 2021, 49(7) : 673-679. [17] Fukui M, Kitagawa Y, Nakamura N,et al. Augmentation of central arterial pressure as a marker of atherosclerosis in patients with type 2 diabetes[J]. Diabetes Res Clin Pract, 2003 Feb,59(2):153-61. [18] Levy BI, Schiffrin EL, Mourad JJ, et al. Impaired tissue perfusion: a pathology common to hypertension, obesity,diabetes mellitus[J]. Circulation, 2008 Aug 26,118(9):968-76. [19] Horton WB, Barrett EJ. Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease[J]. Endocr Rev, 2021 Jan 28,42(1):29-55. [20] Derakhshan A, Bagherzadeh-Khiabani F, Arshi B, et al. Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension,Chronic Kidney Disease[J]. J Am Heart Assoc, 2016 Aug 20,5(8):e003917. [21] Tian X, Zuo Y, Chen S, et al.Hypertension, Arterial Stiffness,Diabetes: a Prospective Cohort Study[J]. Hypertension,2022 Jul,79(7):1487-1496. [22] Li Y, Jiang B, Keehn L, et al.Hemodynamic Mechanism of the Age-Related Increase in Pulse Pressure in Women[J]. Hypertension, 2019 May,73(5):1018-1024. [23] Cao Q, Xin Z, He R, et al. Age-specific difference in the association between prediabetes and subclinical atherosclerosis: an analysis of a chinese prospective cohort study[J]. Cardiovasc Diabetol, 2022 Aug 10,21(1):153. [24] Papadakis J, Ioannou P, Vrentzos G, et al.Impaired Fasting Glucose (IFG) Prevalence Among Hypolipidemic Treatment- naïve Patients with Hypertension[J]. Curr Hypertens Rev, 2022,18(2):153-157. |